# bioAffinity Technologies, Inc.: Form 8-K, filed Aug 14, 2026

- Company: [bioAffinity Technologies, Inc.](/companies/biaf.md) (CIK 1712762)
- Form: 8-K
- Filed: 2026-08-14
- Accepted by EDGAR: Aug 14, 2026, 16:30 ET
- Period: 2026-08-12
- Accession: 0001493152-26-038437
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1712762/000149315226038437/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1712762/000149315226038437/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1712762/000149315226038437/form8-k.htm

Filed Aug 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-038437. Last ingested by Listed: Nov 6, 2026, 18:30 ET. No prices; not investment advice.